Finance

Biogen Shares Soar On “Positive” Alzheimer's Study

Biogen Shares Soar On “Positive” Alzheimer’s Study The pharmaceutical companies Biogen Inc. and Eisai Co. soared premarket after they announced positive results for a drug that slowed the progression of Alzheimer’s disease.  The experimental drug, lecanemab, reduced the progress of the brain-wasting ...